Published Research on AOD-9604 The following peer-reviewed studies are summarized below
Faizan M, Bhat JA, Chen C, Alyemeni MN, Wijaya L, Ahmad P, Yu F (2021) Zinc oxide nanoparticles (ZnO-NPs) induce salt tolerance by improving the antioxidant system and photosynthetic machinery in tomato
Cagrilintide vs AOD 9604 Mechanism: Cagrilintide: Amylin receptor agonist (appetite/satiety) AOD 9604: HGH fragment (fat metabolism) Completely different Weight loss: Cagrilintide: 10-12% body weight AOD 9604: 5-8% body weight (less robust data) Cagrilintide superior Clinical evidence: Cagrilintide: Extensive Phase 2/3 trials AOD 9604: Limited clinical data Cagrilintide better studied Side effects: Cagrilintide: GI effects common AOD 9604: Minimal side effects AOD 9604 better tolerated Combination potential: Could theoretically combine (different mechanisms) No clinical data on combination Cagrilintide + semaglutide better established Verdict: Cagrilintide more powerful, better evidence
Journal of Cutaneous and Aesthetic Surgery, 5 (1), 1719
Our matching methodology puts it at an 77% ingredient match
Animal models of oxidative stress, aging, and therapeutic antioxidant interventions
